newsfilter
← Latest News
PR Newswire·

Aadi Bioscience to Report Third Quarter 2023 Results and Operational Update

Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision therapies for...